london euretina

Instructional Courses

Buy courses during registration or login to your account
if you have already registered

  • Friday 18 September
    08:00-09:30

  • IC 13
  • wetlab prerequisite
    Autofluorescence Imaging-State-Of-The-Art

    F. Holz GERMANY

    Abstract    Schedule

  • Course

    Organiser: F. Holz GERMANY


    Cost: €25

    • 08.00
    • S. Schmitz-Valckenberg  GERMANY

      How to optimize autofluorescence image acquisition


    •  
    • 08.15
    • F. Holz  GERMANY

      Interpreting AF images: a practical approach



    • 08.30
    • A. Tufail  UK

      Autofluorescence imaging in inflammatory diseases


    •  
    • 08.45
    • M. Fleckenstein GERMANY

      The role of autofluorescence in AMD 



    • 09.00
    • T. Theelen THE NETHERLANDS

      Making the correct diagnosis: macular and retinal dystrophies





    • 09.15

    • Discussion

    • 09.30

    • End of course


  • Title:: Autofluorescence Imaging-State-of-the-art

    Abstract:
    Background:
    Fundus autofluorescence (FAF) imaging is a non-invasive imaging method that allows for topographic mapping of naturally or pathological occurring fluorophores at the posterior pole. It is particularly helpful for the assessment of the retinal pigment epithelium/photoreceptor complex and macular pigment distribution.

    Outline:
    The course will start with basic considerations and review of different imaging system for FAF acquisition. The main focus is the clinical interpretation of FAF imaging and its use in the clinical setting, particularly for early disease detection, phenotyping, for identification of prognostic markers, for functional correlation and for the combined application with other innovative imaging modalities.

    Objectives:
    The aim of the course is to give an overview of FAF imaging as a non-invasive and rapid imaging method for the use in various retinal disorders. The course is outlined for participants that have no or minor experience with the technology and that would like to use it in clinical routine.

    Suggested readings:
    1. Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC (2007). Atlas of Fundus Autofluorescence Imaging. Springer. Berlin Heidelberg New York.
    2. Schmitz-Valckenberg S, Fleckenstein M, Scholl HPN, Holz FG (2008). Fundus Autofluorescence and Progression of Age-Related Macular Degeneration. Surv Ophthalmol 54:96-117.
    3. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF (2008). Fundus Autofluorescence Imaging - Review and Perspectives. Retina 28:385-409.
    4. Lois N, Forrester (2009). Fundus Autofluorescence. Wolters Kluwer, Lippincott Williams & Wilkins. Philadelphia Baltimore New York London Buenos Aires Hong Kong Sydney Tokyo.
    Targeted audience:
    Retinal and comprehensive ophthalmologists

    Level:
    Intermediate

  • IC 14
  • wetlab prerequisite
    Current Management of Uveal Melanoma

    D. Pelayes ARGENTINA S. Seregard SWEDEN

    Abstract    Schedule

  • Course Organisers: D. Pelayes ARGENTINA S. Seregard SWEDEN


    Cost: €25

    • 08.00
    • T. Kivela FINLAND

      Pathology



    • 08.10
    • D. E. Pelayes ARGENTINA

      FNAB and biopsy



    • 08.20
    • N. Bechrakis AUSTRIA

      Clinical presentation and differential diagnosis of pseudeomelanomas



    • 08.30
    • S. Seregard SWEDEN

      Brachytherapy



    • 08.40
    • L. Zografos SWITZERLAND

      Proton beam radiotherapy of uveal melanomas



    • 08.50
    • L. Desjardins FRANCE

      Epidemiology



    • 09.00
    • N. Bornfeld GERMANY

      Local Resection (Endoresection)



    • 09.10
    • E. Midena ITALY

      Metastatic uveal melanoma



    • 09.20
    • D. Pelayes ARGENTINA,

      S. Seregard SWEDEN

      Discussion/ Questions




    • 09.30

    • End of course


  • Current Management in Uveal Melanoma

    Synopsis: This course will cover the current diagnosis and treatment in uveal melanoma including correct diagnosis, histological classification, prognostic factors, new diagnosis methods and the latest treatment options, including thermotherapy, plaque radiotherapy, local resection, enucleation and orbital exenteration. Various cases with discussion of management will be provided.

    Course Objective The attendee should be able to recognize the clinical manifestations of the uveal melanoma and plan appropriate management.


  • Friday 18 September
    08:00-10:00

  • IC 15
  • wetlab prerequisite
    Current Strategies in Ocular Trauma

    C. Forlini ITALY J. Nikolakapoulos GREECE

    Abstract    Schedule



  • Course Directors: C. Forlini ITALY


    Moderators: C. Forlini ITALY, A. Nikolakopoulos GREECE


    Cost: €25

    • 08.00
    • S. Natarajan INDIA

      "Management of severe ocular trauma - Three situations 1. Endophthalmitis 2. Intra- ocular foreign bodies 3. Suprachoroidal hemorrhage."



    • 08.10
    • A. Nikolakopoulos GREECE

      Trauma and dropped lens, papanikolaou MIVS technique in removing dropped lens bimanualy without fragmentation ,and our way of an easy endoscleral suturless IOL incertion



    • 08.20
    • P. Szurman GERMANY

      Iris reconstruction in traumatic aniridia



    • 08.30
    • M. Forlini ITALY

      Case Report: "Iris trauma: the different way of iris reconstruction



    • 08.37
    • C. Forlini ITALY

      Pole to Pole" surgery in severe ocular trauma: Focus on the "middle earth" using the artificial Iris



    • 08.47
    • P. Sullivan UK

      How not to do it - Mistakes during primary repair"



    • 08.57
    • F. Fayyad JORDAN

      Severe posterior eye injury with hemorrhagic choroidal detachment and rhegmatogenous retinal detachment"



    • 09.07
    • K. Sabti KUWAIT

      Managing severely traumatized eyes with the endoscope "



    • 09.17
    • M. Nagpall INDIA

      Multiple surgeries with post operative PFCL retention for a case of penetrating trauma with lens expulsion



    • 09.27
    • H. Mortada EGYPT

      Combined chorioretinectomy and ILM peeling for prophylaxis of recurrent proliferation in open globe injuries



    • 09.37
    • W. Schrader GERMANY

      Management of a bilateral perforating injury caused by two teeth of a circular saw



    • 09.44
    • T. Imshanetskaya BELARUS

      Simultaneous penetrating keratoplasty and glaucoma valve drainage in patient with
      traumatic glaucoma



    • 09.51
    • C. Forlini ITALY,

      A. Nikolakopoulos GREECE

      Conclusion




    • 10.00

    • End of course


  • 0

  • IC 16
  • wetlab prerequisite
    Management of Retinal Vascular Occlusion

    G. Lang GERMANY N. Feltgen GERMANY

    Abstract    Schedule



  • Organiser: G. E. Lang GERMANY


    Cost: €25

    • 08.00
    • G. E. Lang GERMANY

      Diagnostic procedures in retinal vein occlusions (RVO)



    • 08.20
    • A. Pielen GERMANY

      Update on pharmacological treatment in RVO



    • 08.40
    • G. E. Lang GERMANY

      Laser treatment in RVO



    • 09.00
    • H. Heimann UK

      Is there still a role for surgical treatment in RVO?



    • 09.20
    • N. Feltgen GERMANY

      Diagnosis and treatment of retinal artery occlusion (RAO)


    • 09.40

    • Discussion

    • 10.00

    • End of course


  • 0

  • IC 17
  • wetlab prerequisite
    Current Management of ROP and Pediatric Vitreo-Retinal Diseases

    A. Kychenthal CHILE G. Caputo FRANCE

    Abstract    Schedule



  • Course Leaders/Organisers: A. Kychenthal CHILE, G. Caputo FRANCE


    Cost: €25

    • 08.00
    • P. Dorta CHILE

      Pediatric retinal imaging
      paoladorta@kydoft.cl,



    • 08.15
    • M. Trese USA

      Familial exudative vitreoretinopathy (FEVR)
      mgjt46@aol.com,



    • 08.30
    • K. Tawansy USA

      Type 1 ROPT, current management
      ktawansy@childrensretina.com



    • 8.45
    • A. Kychenthal CHILE

      ROP retinal detachment
      akychenthal@kydoft.cl



    • 09.00
    • G. Caputo FRANCE

      Coats disease and persistent fetal vasculature syndrome (PFV)
      gcaputo@fo-rothschild.fr



    • 09.15
    • M. Shapiro USA

      Familial exudative vitreoretinopahy
      michaelj.shapiro@gmail.com



    • 09.30
    • C. Wong UK

      Retinoschisis
      chien22@yahoo.com


    • 09.45

    • Discussion

    • 10.00

    • End of course



  • Title::Current Management of ROP and Pediatric Vitreo-Retinal Diseases




    Course Leader:
    Andres Kychenthal & Georges Caputo

    Audience Level: Retina specialists and comprehensive ophthalmologists with an interest in pediatric retina
    Intermediate Level


    Format Options:
    Didactic presentations with scheduled questions and answers managed by the course directors.

    Background:
    Pediatric vitreoretinal diseases represent a significant proportion of treatable blinding disorders in the world. Pediatric Vitreoretina is a rapidly growing subspecialty. A course dedicated to pediatric vitreoretinal diseases contributes to EURETINA in providing attendees with specific information in this essential area.

    Outline: This course presents the current management of Retinopathy of Prematurity and other important pediatric vitreoretinal disorders.

    Objectives: The course deals with the diagnosis and surgical treatment of ROP, Coats disease, Persistent Fetal Vasculature Syndrome , non-ROP retinal detachments, Familial Exudative Vitreoretinopathy (FEVR), Juvenile Retinoschisis and other conditions. The use of pediatric retinal imaging will be also addressed. Specific pharmacological therapy including anti -VEGF drugs and different surgical techniques and adequate timing of intervention will be discussed.
    At the conclusion of this course the attendee will be able to correctly identify the best diagnostic and therapeutic tools for main pediatric vitreoretinal diseases.

  • IC 18
  • wetlab prerequisite
    Clinical Visual Electrophysiology

    G. Holder UK

    Abstract    Schedule

  • Course

    Organiser: G. Holder UK


    Cost: €25

    • 08.00
    • G. Holder UK

      An introduction to the tests
      graham.Holder@moorfields.nhs.uk



    • 08.25
    • B. Leroy BELGIUM

      Electrophysiology and inherited disease
      bart.leroy@ugent.be



    • 08.50
    • D. Thompson UK

      Paediatric electrophysiology
      Dorothy.Thompson@gosh.nhs.uk



    • 09.15
    • G. Holder UK

      Electrophysiology in acquired and inflammatory disease


    • 09.40

    • Discussion

    • 10.00

    • End of course



  • Outline:

    The Course will address the use of visual electrophysiology in routine clinical practice. After an introductory lecture explaining the tests and their anatomical origins, there will be lectures to demonstrate the role of electrophysiological testing both in inherited and in acquired retinal disorders, illustrating their contribution both to diagnosis and on management. There will also be a presentation addressing the use of electrophysiology in paediatric practice, where electrophysiology has a particularly important role by providing objective functional data even when the patient is unable to give a history or describe their symptoms. All lecturers will use a case-based approach better to enable the audience to appreciate the clinical value of the tests

    Objectives and Conclusion:

    The attendees will understand the nature and origins of the main electrophysiological tests, and be aware how those tests can be applied to clinical practice, both as diagnostic tools and also as measures that objectively enable both demonstration of disease severity and of the response to therapeutic intervention (if applicable). They will understand the principles of basic test interpretation and ERG diagnosis. Their knowledge of the underlying disorders and pathophysiology should be improved.

    Course Instructors:

    Prof Graham E Holder, Moorfields Eye Hospital, London, UK (graham.holder@moorfields.nhs.uk);

    Prof Bart P Leroy, University of Ghent, Belgium (bart.leroy@ugent.be);

    Dr Dorothy A Thompson, Great Ormond Street Hospital for Children, London, UK (Dorothy.Thompson@gosh.nhs.uk)

  • Friday 18 September
    11:00-12:30

  • IC 19
  • wetlab prerequisite
    Surgical Approach to the Vitreoretinal Interface

    P. Brazitikos GREECE

    Abstract    Schedule

  • Course

    Organiser: P. Brazitikos GREECE


    Cost: €25

    • 11.00
    • P. Brazitikos GREECE

      Vitreomacular traction: Lamellar macular holes



    • 11.15
    • F. Devin FRANCE

      Myopic foveoschisis



    • 11.30
    • A. Gaudric FRANCE

      Macular hole surgery: New trends



    • 11.45
    • S. Rizzo ITALY

      Macular pucker



    • 12.00
    • A. Augustin GERMANY

      Diabetic macular edema



    • 12.15
    • S. Androudi  GREECE

      Ocriplasmin and its role in the management of vitreoretinal interface disorders



    • 12.30

    • End of course


  • Title:: Surgical Approach to the Vitreoretinal Interface

    Course

    Organiser: P. Brazitikos GREECE

    Targeted audience and level
    Retina specialists
    Intermediate/ Advanced Level

    Format.
    Didactic presentations with scheduled questions and answers managed by the course director.

    Course Abstract
    The abnormalities of the vitreoretinal interface may contribute to important medical and surgical retinal pathologies. This course will cover the following important entities: lamellar macular holes, myopic foveoschisis, macular hole, macular pucker and diabetic macular edema.
    At the conclusion of this course the attendee will be able to identify these different clinical entities and provide to the patient the optimal therapeutic intervention.


  • IC 20
  • wetlab prerequisite
    Basic Technical Aspects Of Minimal Invasive Vitrectomy

    C. Pruente SWITZERLAND

    Abstract    Schedule

  • Course

    Organiser: C. Prünte SWITZERLAND
    Cost :€25

    • 11.00
    • A. Augustin GERMANY

      Managing retinal detachment



    • 11.20
    • J. Garcia-Arumi SPAIN

      Safety aspects of minimal invasive vitrectomy



    • 11.40
    • J. Korobelnik FRANCE

      Managing diabetic retinopathy and other proliferative diseases



    • 12.00
    • C. Prünte SWITZERLAND

      Basic technical aspects of minimal invasive vitrectomy



    • 12.20

    • Discussion

    • 12.30

    • End of course



  • Abstract


    Course "Minimal Invasive Vitrectomy"

    Minimal invasive vitrectomy gains more and more acceptance in the surgical management of vitreo-retinal diseases. Today self-sealing techniques using 23, 25 and 27 Gauge inserts are used. These methods are characterized by smaller diameter instrumentation. In order to guarantee sufficient efficiency and maximal safety various aspects have to be considered. In principle small diameter aspiration systems are correlated with reduced flow and the instruments lack stability. Therefore the surgeon needs to consider technical aspects of various pump systems and settings, which can be selectively used in various procedures during the surgery. Furthermore specific technical developments in instrumentation contribute to facilitate surgery and thus increase safety and efficacy.

    An extremely important aspect is the adaptation of surgical techniques and procedures to optimally apply the possibilities modern technical advances provide.
    This course will explain and demonstrate the basic technical aspects and options as well as surgical techniques adapted to minimal invasive vitrectomy. The presentations provide theoretical considerations and surgical case presentation to demonstrate practical aspects.

  • IC 21
  • wetlab prerequisite
    Eye & Brain: OCT in Central Nervous System Diseases

    A.   Grzybowski POLAND

    Abstract    Schedule



  • Course Leader:
    A. Grzybowski POLAND


    Cost: €25

    • 11.00
    • A. Grzybowski POLAND

      Eye and brain - Introduction



    • 11.05
    • V. Parisi ITALY

      Correlation between OCT and neural conduction along the visual pathways in multiple sclerosis



    • 11.20
    • C. Arndt FRANCE

      OCT and pharmacological treatment



    • 11.35
    • F. Cordeiro UK

      Animal model in neurophthalmology



    • 11.50
    • F. Pichi ITALY

      OCT in amblyopia



    • 12.05
    • A. Grzybowski POLAND

      OCT in migraine, schizophrenia, and obstructive sleep apnea-hypopnea syndrome (OSAHS)



    • 12.20

    • Discussion

    • 12.30

    • End of course


  • Title:: Eye & Brain: OCT in Central Nervous System Diseases


    Format Options: Didactic presentations with scheduled questions and answers managed by the course director

    Abstract and outline
    Optical coherence tomography (OCT) is a noninvasive imaging technique that allows us to monitor the retinal nerve fiber layer (RNFL). This structure contains the axons of the retinal ganglion cells, which form the optic nerves, chiasm and optic tracts. Since retinal axons are nonmyelinated until they penetrate the lamina cribrosa, the RNFL is an ideal structure to visualize any process of neurodegeneration, neuroprotection or regeneration. Therefore, OCT has been applied in several areas in neurology over the last decade, becoming a hot topic and generating great enthusiasm among neurologists and ophthalmologists. The use of OCT to quantify retinal axonal loss is a promising tool to evaluate disease progression in numerous neurodegenerative disorders, including multiple sclerosis, Parkinson disease, Alzheimer disease, intracranial hypertension, and schizophrenia and may be used as a biological marker of neuroaxonal injury. An overview of the advancements in the development of OCT as a novel technology that enables objective analysis of the processes of neurodegeneration within the retina will be given.

    Suggested readings
    1. London A. et al. The retina as a window to the brain —from eye research to CNS disorders. Nat Rev Neurol 2013; 9:44-53.
    2. Sivak JM. The aging eye: common degenerative mechanisms between the Alzheimer’s brain and retinal diseases. IOVS 2013; 54: 871-880.
    3. Petzold A et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 921–32.
    4. Simao LM. The contribution of optical coherence tomography in neurodegenerative diseases. Curr Opin Ophthalmol. 2013;24:521-7.
    5. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration. Neurotherapeutics 2011; 8: 117-132.




    Course Description: The course will present the use of OCT in different Central Nervous System Diseases.
    Course Objectives:
    - To present the value of OCT in MS, Amblyopia, Migraine, Schizophrenia, and Obstructive Sleep Apnea-Hypopnea Syndrome
    - To discuss the values of OCT in animal model studies

    Conclusion: At the conclusion of this course the attendee will be able to describe the correlation between OCT and neural conduction in Multiple Sclerosis, discuss OCT changes and Pharmacological Treatment, Animal model in Neurophthalmology, OCT in Amblyopia, and OCT in Migraine, Schizophrenia, and Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS).



  • IC 22
  • wetlab prerequisite
    Polypoidal Choroidal Vasculopathy: Diagnosis & Treatment

    R. Silva PORTUGAL

    Abstract    Schedule



  • Moderators: R. Silva PORTUGAL

    A. Koh SINGAPORE



    Cost: €25


    • 11.00
    • R. Silva PORTUGAL

      Introduction
      rufino.silva@oftalmologia.co.pt



    • 11.02
    • A. Carneiro PORTUGAL

      PCV characterization: An overview
      amvgcarneiro@gmail.com



    • 11.14
    • G. Staurenghi ITALY

      The diagnosis: Multimodal imaging of PCV: Color images, Autofluorescence,Infrared reflectance, OCT, OCT-Angio, FA, ICGA
      giovanni.staurenghi@unimi.it



    • 11.32
    • M. Falcão PORTUGAL

      The differential diagnosis: CSC, nAMD; tumors, others
      falcao.manuel@gmail.com



    • 11.42
    • A. Koh SINGAPORE

      The treatment: anti-VEGF monotherapy, combined treatments, how and when to treat and re-treat
      ahckoh@yahoo.com



    • 12.00
    • R. Silva PORTUGAL

      PCV management: Clinical cases




    • 12.18

    • Discussion

    • 12.30

    • End of course


  • Title:: Polypoidal choroidal vasculopathy: Diagnosis and treatment



    Moderators: Rufino Silva, Adrian Koh




  • IC 23
  • wetlab prerequisite
    Managing Complications in Vitreoretinal Surgery

    P. Sullivan UK

    Abstract    Schedule

  • Course

    Organiser: P. Sullivan UK



    Cost: €25


    • 11.00
    • P. Sullivan UK

      Complications of scleral buckling



    • 11.12
    • A. Laidlaw UK

      Retinal trauma during vitrectomy



    • 11.24
    • C. Pavesio UK

      Inflammation and infection after vitreoretinal surgery



    • 11.36
    • P. Sullivan UK

      Post vitrectomy cataract



    • 11.48
    • K. Barton UK

      Glaucoma after vitreoretinal surgery



    • 12.00
    • A. Laidlaw UK

      Complications of diabetic vitrectomy



    • 12.12
    • P. Sullivan UK

      Intraocular haemorrhage during vitrectomy


    • 12.24

    • Discussion

    • 12.30

    • End of course


  • Title::
    Complications in Vitreoretinal Surgery




    Course Leader:
    Paul Sullivan

    Audience Level: Retina specialists - Intermediate

    Format Options:
    Didactic presentations with scheduled questions and answers managed by the course director
    Abstract and outline

    Because of its innate complexity complications are relatively frequent in vitreoretinal surgery, especially during the learning curve. Many of these complications are avoidable.



    Course Description:

    In this course complications will be classified and dealt with according to the underlying pathogenic mechanisms:
    Cataract
    Retinal trauma
    Choroidal haemorrhage
    Complications of diabetic vitrectomy
    Complications of scleral buckling surgery
    Inflammation and infection following vitreoretinal surgery


    Course Objectives:

    At the end of the course participants will be familiar with the causes, pathogenic mechanisms and management (including both treatment and prevention) of each of these.

    Conclusion: Participants will be better able to manage common complications of vitreoretinal surgery.

  • Friday 18 September
    14:30-16:00

  • IC 24
  • Multi-modal OCT imaging: Research and Routine

    U. Schmidt-Erfurth AUSTRIA

    Abstract    Schedule

  • Course

    Organiser: U. Schmidt-Erfurth AUSTRIA


    Cost: €25

    • 14.30
    • U. Chakravarthy UK

      Diabetic retinopathy: Imaging pathophysiology



    • 14.45
    • U. Schmidt-Erfurth AUSTRIA

      Exudative AMD: Biomarkers of disease and therapy



    • 15.00
    • P. Roberts AUSTRIA

      Geographic atrophy: Relevant features and modalities



    • 15.15
    • P. Stanga UK

      Choroidal imaging: Value and indications



    • 15.30
    • S. Waldstein AUSTRIA

      Computational image analysis: The future is here to stay



    • 15.45
    • M. Pircher AUSTRIA

      Adaptive optics OCT: Ready for use?




    • 16.00

    • End of course


  • IC 25
  • wetlab prerequisite
    Macular Edema. Guidelines and Treatment Algorithms

    P. Tranos GREECE

    Abstract    Schedule

  • Course

    Organiser: P. Tranos GREECE



    Cost: €25

    • 14.30
    • R. Hamilton UK

      Pathophysiology of Macular edema



    • 14.40
    • P. Hykin UK

      Diabetic macular edema



    • 14.50
    • A.Tufail UK

      Retinal Vein Occlusion



    • 15.00
    • P. Neri ITALY

      Macular edema and ocular inflammatory diseases



    • 15.10
    • T. Vakalis GREECE

      Postoperative macular edema



    • 15.20
    • M. Sagoo UK

      Oncology related macular edema



    • 15.30
    • P. Tranos GREECE

      Macular edema and inherited dystrophies



    • 15.40
    • J. van Meurs NETHERLANDS

      Macular edema and tractional disorders



    • 15.50

    • Discussion

    • 16.00

    • End of course


  • Title:: Macular Edema. Guidelines and treatment algorithms.



    Course Leader:
    Paris Tranos

    Audience Level: Retina specialists/Comprehensive ophthalmologists/ Beginner / Intermediate / Advanced

    Format Options:
    Didactic presentations with scheduled questions and answers managed by the course director

    Abstract and outline
    Macular edema is the final common pathway of many intraocular and systemic insults. It may develop in a diffuse pattern where the macula appears generally thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with protean underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, diabetic retinopathy, and posterior segment inflammatory disease. As well as clinical suspicion, a wide range of investigations may lead to the diagnosis of macular edema. Fluorescein angiography and optical coherence tomography provide enhanced visualization of the geometry and distribution of macular edema. A variety of approaches to the treatment of macular edema have been attempted, with a variable degree of success. The current evidence supporting these options and the clinical trials investigating novel therapeutic choices are presented. This instructional course will encourage through interactive sessions, active discussion of several clinical examples, focusing on the current therapeutic strategies for the management of macular edema.

    Outline Pathophysiology of macular oedema
    Diabetic macular oedema
    Retinal vein occlusion
    Oncology related macular edema
    Macular edema and ocular inflammatory diseases
    Postoperative macular edema
    Macular edema and inherited dystrophies
    Macular edema and tractional disorders


    Yeh S, Kim SJ, Ho AC, Schoenberger SD, Bakri SJ, Ehlers JP, Thorne JE Therapies for Macular Edema Associated with Central Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology.Ophthalmology. 2015 Jan 8.
    Guo S, Patel S, Baumrind B, Johnson K, Levinsohn D, Marcus E, Tannen B, Roy M, Bhagat N, Zarbin M.Management of pseudophakic cystoid macular edema.Surv Ophthalmol. 2015 March - April;60(2):123-137
    Arevalo JF. Diabetic macular edema: changing treatment paradigms. Curr Opin Ophthalmol. 2014 Nov;25(6):502-7
    Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90.

    Course Objectives:
    To provide both basic and in depth knowledge of the pathophysiology, diagnosis and management of macular edema
    Flow charts and treatment algorithms will be provided to participants. Interactive sessions will enhance better understanding of equivocal cases.

    Conclusion: The participants will be updated on the current, evidence based trends on diagnosis and management of various types of macular edema.

  • IC 26
  • wetlab prerequisite
    Retinal Vascular Diseases: A Critical Appraisal

    A. Grosso ITALY E. Sigler USA L. Arias SPAIN

    Abstract    Schedule



  • Chairperson: E. Sigler USA
    Panel: L. Arias SPAIN, A. Grosso ITALY, J. Ruiz-Moreno SPAIN

    • 14.30
    • M. Pellegrini ITALY

      Diabetic choroidopathy: seeing beyond diabetic retinopahty



    • 14.37
    • J. Ruiz-Moreno SPAIN

      Diabetic choroidopathy: the experience with OCT swept-source



    • 14.44
    • A. Grosso ITALY,

      E. Sigler USA

      AMD and diabetic retinopathy




    • 14.51
    • E. Sigler USA

      Coats disease: some answers, more questions



    • 14.58
    • G. Prigione ITALY

      Von Hippel Lindau disease: current perspectives and management




    • 15.05
    • A. Grosso ITALY

      IRVAN disease and an epistemological premise in the management of retinal vasculitis



    • 15.12
    • G. Pertile ITALY
      Peripheral exudative hemorrhagic chorioretinopathy (PEHCR): a new clinical entity?


    • 15.12

    • Section 2: Controversies in the (para) surgical management of retinal vascular diseases



      Chairperson: L. Arias SPAIN


    • 15.12

    • Panel: E. Sigler USA, G. Pertile ITALY, J. Calzada USA

    • 15.19

    • J. Calzada USA

      Management of proliferative diabetic retinopathy in the era of small gauge surgery



    • 15.26
    • C. Panico ITALY

      video presentation: 27-gauge surgery in diabetic proliferative disease



    • 15.33
    • L. Arias SPAIN

      Cataract surgery and DME: Anti VEGF or Ozurdex, before or during surgery?



    • 15.40
    • L. Arias SPAIN

      DME and vitrectomy: last resort?



    • 15.47
    • A. Giani ITALY

      Does laser still have a role in the management of retinal vascular and neovascular diseases? Towards a new paradigm of multimodal sequential therapies and the advent of subthreshold micropulse diode laser in DME: quiet addiction or game changer?


    • 15.54

    • Discussion

    • 16.00

    • End of course


  • Title:: Retinal vascular diseases: a critical appraisal


    Abstract
    Purpose: to stimulate a critical debate about new diagnostic modalities and current paradigms of treatment for selected retinal vascular disorders.
    Background: multimodal retinal imaging and new advancements in vitreoretinal surgery have shed new light in the management of retinal vascular diseases
    Methods: we have structured the course in two sections: the first part includes brief communications focused to diabetic choroidopathy, diabetic retinopahty and age-related macular degeneration, Coats disease, IRVAN disease and peripheral exudative hemorrhagic chiorioretinopathy.
    The second part of the course is mainly centered to the controversies in the parasurgical and surgical management of selected retinal vascular diseases: diabetic macular edema and cataract surgery, proliferative diabetic retinopathy in the era of 27-gauge vitrectomy, role of the laser in the prevention and treatment of macular edema and neovascularisation following diabetic retinopathy and retinal vein occlusions.
    Course objectives: we hope to cover some tricky clinical scenarios in our daily practice rather than provide colleagues with a cooking book of recommendantions or guidelines. The presentations will start from clinical cases and we encourage an interactive participation. At the conclusion of this course the attendee will be able to have a practical guidelines to manage retinal exudative retinopathies and to better translate the significance of multimodal imaging to the daily practice.

  • IC 27
  • wetlab prerequisite
    Chromovitrectomy: Novel Vital Dyes and Illumination Systems for Vitreoretinal Surgery

    C.   Meyer SWITZERLAND E.B.   Rodrigues BRAZIL

    Abstract    Schedule

  • Chairpersons: C. H. Meyer SWITZERLAND, E. B. Rodrigues BRAZIL


    Cost: €25

    • 14.30
    • B. V. Stanzel GERMANY

      Impact of RPE cell cutures for the development on novel dyes



    • 14.42
    • M. Lueke GERMANY

      Impact of retinal cell perfusion for the development on novel dyes



    • 14.54
    • C. Haritoglou GERMANY

      Histological considerations after chromovitrectomy



    • 15.06
    • B. Henrich SWITZERLAND

      Illumination and contrast: impact of the lightsource on the contrast of vital dyes



    • 15.18
    • R. Tadayoni FRANCE

      Benefit of chromovitrectomy to visualize epiretinal membranes



    • 15.30
    • S. Rizzo ITALY

      Ala purple: a novel dye for chromovitrectomy



    • 15.42
    • E. Rodrigues BRAZIL

      Future perspective in chromovitrectomy


    • 15.54

    • Discussion

    • 16.00

    • End of course


  • Abstract:
    Vital dyes have become a frequent tool for modern vitreo-retinal surgery. The dyes stain semi-transparent structures at the vitro-retinal surface, to assist a safe surgical removal (chromovitrectomy). While initial dyes may induce toxic effects to the neuroretina and RPE, novel dyes have become available to avoid toxic side effects. Today, a variety of approved dyes have become available to stain e.g. the vitreous, a-cellular structures (ILM) or cellular structures (ERM, PVR). The staining effect and safety profile of frequently used dyes and illumination systems have been evaluated in great detail. The experimental and clinical results will be presented and discussed to guide and assist vitreo-retinal surgeons in their routine selection of these dyes.

  • Friday 18 September
    16:30-18:00

  • IC 28
  • wetlab prerequisite
    The Intra-Ocular Mirror Telescope as Additive Treatment for AMD Eyes: Patient Selection, Surgical Technique & Clinical Results

    I. Lipshitz ISRAEL A. Loewenstein ISRAEL

    Abstract    Schedule



  • Course Leader:
    I. Lipshitz ISRAEL


    Cost: €25

    • 16.30
    • I.Lipshitz ISRAEL

      Introduction and advantages of implanted telescopes



    • 16.45
    • I. Lipshitz ISRAEL

      Concept and design- Description, specification, performance



    • 17.00
    • A. Loewenstein ISRAEL

      Patient selection, examination and education



    • 17.15
    • I. Lipshitz ISRAEL,

      A. Loewenstein ISRAEL

      Clinical experience



    • 17.30
    • I.Lipshitz ISRAEL

      Future mirror implanted products


    • 17.38

    • Discussion

    • 18.00

    • End of course


  • Title::
    The Intra-Ocular Mirror Telescope as additive treatment for AMD Eyes: Patient selection, surgical technique and clinical results.



    Course Leader:


    Isaac Lipshitz MD

    Audience Level:Intermediate


    Course Description:
    Treatments of AMD are intended only for wet type while the vast majority has no treatment. The implanted mirror telescope is an additive treatment for any type of AMD, at any stages and for phakic as well as pseudophakic eyes.

    Course Objectives:
    The course explains the optical design, the surgical technique, clinical results and visual filed created by the intra ocular implanted mirror telescope.
    The treatment is additive to other AMD treatments and is reversible (can be easily explanted with no damage). Patient selection criteria will be explained; the postop vision and contrast can be simulated and presented before surgery is done.
    The mirror telescope comes in several versions: "in the bag", pseudophakic and lately also as an "anterior chamber" implant.

    Conclusion:
    At the conclusion of this course the attendee will understand the optical design of the different telescopes, how to select suitable patients for implantation, and familiarize with the surgical technique as well as the expected clinical results and handling possible complications.



  • IC 29
  • wetlab prerequisite
    Uveitis- New Insights and Interesting Cases

    M.   Funk AUSTRIA H.J.   Kaplan USA

    Abstract    Schedule

  • Course Organisers: H. J. Kaplan USA, M. Funk AUSTRIA


    Cost: €25


    • 16.30
    • H. Kaplan USA

      Update on diagnosis and treatment



    • 16.50
    • M. Funk AUSTRIA

      Update on imaging



    • 17.10
    • M. Funk AUSTRIA

      Interesting cases



    • 17.30
    • H. Kaplan USA

      Interesting cases


    • 17.50

    • Discussion

    • 18.00

    • End of course


  • Title::
    Uveitis –New Insights and Interesting Cases

    Audience Level: Retina specialists/Comprehensive ophthalmologists/ Beginner / Intermediate / Advanced

    Format Options:
    Didactic presentations with scheduled questions and answers managed by the course director
    Case presentation: Case presentations/discussion between panelists and with the audience
    Hands-on skills transfer courses

    Abstract and outline

    Uveitis comprises a broad range of intraocular inflammatory diseases with various etiologies and multiple therapeutic options. The course gives an overview about the most important new developments in diagnosis, therapy and imaging technologies in the field of uveitis.
    Oral presentations providing an update on diagnosis and treatment will be followed by case presentations to provide a practice-oriented approach in managing interesting uveitis cases.
    At the conclusion of this course the attendee will understand new developments in diagnosis and therapy in uveitis patients, as well as how to approach complicated cases.





  • IC 30
  • wetlab prerequisite
    Morphological Biomarkers Of Interest In The Era Of Wide Field Imaging & High Resolution Tomography

    U. Chakravarthy FRANCE

    Abstract    Schedule



  • Chairperson: U. Chakravarthy UK


    Cost: €25

    • 16.30
    • G. Staurenghi ITALY

      Wide field optical coherence tomography



    • 16.45
    • V. Sadda USA

      Grading vascular perfusion in RWF and the ageing vasculature



    • 17.00
    • T. Peto UK

      Retinal WF imaging optimisation, interpretation and applications



    • 17.15
    • R. Hogg UK

      Retinal WF imaging in the NICOLA study



    • 17.30
    • U. Chakravarthy UK

      Retinal WFI quiz



    • 17.45

    • Discussion

    • 18.00

    • End of course


  • Morphological biomarkers of interest in the era of high resolution tomography


    Purpose. To describe new developments in fundus imaging



    Course Description:



    Descriptions of wide field optical coherence tomography and ultrawide filed colour and angiographic fundus photography and currently available acquisition systems.
    Learning points will include acquisition, optimisation and interpretation of findings from wide field imaging modalities.
    In addition how these imaging technologies may provide novel biomarkers for prediction of development and or progression to late stage AMD and diabetic retinopathy will be explored.

    Conclusions: The course will conclude with a quiz on peripheral retinal pathology

EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy